Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. The platform uses AI agents to draft regulatory documents such as CTDs, CSRs, INDs, and BLAs in minutes rather than weeks. Key capabilities include automated document drafting in Microsoft Word with FDA formatting compliance, intelligent document retrieval from SharePoint and Veeva, and automated follow-ups via Outlook integration. Ritivel was founded in 2025 and is part of Y Combinator's Winter 2026 batch.
Ritivel
ActiveAI-native platform for Life-Sciences Documentation
Total raised
$500K
1 round
Stage
Seed
Jan 2026
Team
1-10
since 2026
Pricing
—
Founded
2026
San Francisco, United States
Agent-ready
—
AI agents that draft regulatory documents (CTDs, CSRs, INDs, BLAs)
Document drafting directly in Microsoft Word
FDA formatting compliance built into generated documents
Intelligent document retrieval from SharePoint and Veeva
Automated follow-ups via Outlook integration
AI-native workspace for regulatory and medical writing teams
Drafting in minutes rather than weeks
12/100
Early
MCP server
Public API
Webhooks
OAuth 2.0
SDKs
No public agent surfaces detected yet.
Jan 2026 Seed $500K ● Y Combinator
Capital network
$500K raised ·1 backer·10 network links
- Backers1
- Shared portfoliocompanies these backers also fund
- Extended networkfunds that co-invest alongside them
Pearl Health
AI value-based care platform for primary care providers
AI AnalyticsAI Healthcare
Commure
AI Healthcare
Innovaccer
AI Healthcare
Truveta
AI Healthcare
Terray Therapeutics
Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery
AI HealthcareDrug Discovery
Genesis Molecular AI
Generative AI for small-molecule drug discovery
AI HealthcareDrug Discovery
- Which documents can Ritivel draft?
- Its AI agents draft regulatory documents such as CTDs, CSRs, INDs, and BLAs, with FDA-compliant formatting.
- Does it work with tools my team already uses?
- Yes. It drafts in Microsoft Word, retrieves documents from SharePoint and Veeva, and automates follow-ups through Outlook integration.
- Does Ritivel replace regulatory writers?
- It is positioned as an AI-native workspace that accelerates drafting from weeks to minutes, but regulatory submissions still require expert human review and oversight.
- Who is Ritivel for?
- It is built for regulatory and medical writing teams at life sciences companies.
Discussion
Sign in to join the discussion.
Sign inExplore more around Ritivel
Contextual paths to related AI startups, deals and rankings.